Form 4: Cigna Director Granger Elder Executes Stock Option and Sells Shares Under 10b5-1 Plan

Director Granger Elder exercised stock options and sold Cigna shares under a pre-arranged 10b5-1 trading plan.

Summary

• On June 12, 2024, Cigna Group Director Granger Elder executed a transaction involving the company's stock.
• Elder exercised stock options to acquire 1,000 shares of common stock at a price of $175.0938 per share.
• Simultaneously, Elder sold 1,000 shares of common stock at a price of $338.08 per share.
• These transactions were conducted under a Rule 10b5-1 trading plan adopted on March 13, 2024.
• Following these transactions, Elder directly owns 5,471 shares of Cigna common stock and options to purchase 547 shares.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing insider transactions. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about stock transactions.

Industry Context

This Form 4 filing is a routine disclosure of insider transactions, which are common in publicly traded companies. The use of a 10b5-1 trading plan suggests that the transactions were pre-planned and not based on any material non-public information.

Comparison to Industry Standards

• Form 4 filings are standard practice for directors and officers of publicly traded companies like Cigna, similar to filings made by insiders at UnitedHealth Group (UNH), Anthem (ANTM), and Humana (HUM).
• The use of a 10b5-1 trading plan is a common method employed by corporate insiders to sell shares over time, mitigating concerns about insider trading, a practice also seen at companies like CVS Health and Centene.

Stakeholder Impact

• The transactions may have a minor impact on shareholders due to the director's sale of shares, but the use of a 10b5-1 plan suggests the transactions were pre-planned and not based on current company performance.

Key Dates